Neos Therapeutics Inc 's

Name: Neos Therapeutics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NEOS Sales vs. its Competitors Q3 2018

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Neos Therapeutics Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< NEOS Stock Performance Comparisons

<< See the full list of NEOS competitors

*Market share is calculated based on total revenue.

NEOS's Stock Performance relative to its Competitors

Publicly Traded Peers of Neos Therapeutics Inc

Regencell Bioscience Holdings Limited
Share Performance

-75.81%

This Quarter

Regencell Bioscience Holdings Limited

Profile

Regencell Bioscience Holdings Limited operates under a business model that focuses on the development and commercialization of advanced biotechnology products. The company employs research and development to create innovative solutions in the field of cell therapy, regenerative medicine, and related technologies. Through strategic partnerships and collaborations, Regencell aims to bring its products to market to address various medical conditions and contribute to the growth of the biotech industry.

More about Regencell Bioscience Holdings Limited's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 2,891.573 mill.	$ - mill.	$ -3.584 mill.

Zevra Therapeutics Inc
Share Performance

+3.78%

Over The Past 5 Days

Zevra Therapeutics Inc

Profile

Zevra Therapeutics Inc operates on a business model that focuses on the development and commercialization of innovative therapeutics.

More about Zevra Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 733.842 mill.	$ 115.073 mill.	$ 124.218 mill.

Sources: Neos Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, July 7, 2026 1:57 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Neos Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.